Anky's Laboratories

Products

High-purity APIs across therapeutic categories.

Our diversified portfolio spans chronic and acute therapy areas, backed by validated processes, DMF support, and reliable global supply.

Download Full Catalogue (PDF)Request a Quote
80+
APIs in portfolio
30+
Advanced intermediates
12
Active DMFs
5
Therapy areas

Browse by category

Find your product

Search by product name or CAS number, then narrow by therapy area and status.

Status
Category
12+ products

Cardiovascular

Statins, antihypertensives, and antiplatelets for chronic cardiac therapy.

Category brochure
Product
CAS Number
Status
  • Atorvastatin Calcium
    134523-03-8
    Commercial
  • Rosuvastatin Calcium
    147098-20-2
    Commercial
  • Clopidogrel Bisulfate
    120202-66-6
    Commercial
  • Telmisartan
    144701-48-4
    Commercial
  • Amlodipine Besylate
    111470-99-6
    Commercial
Request cardiovascular quote
9+ products

Anti-Diabetic

Biguanides, DPP-4 inhibitors, and SGLT-2 inhibitors.

Category brochure
Product
CAS Number
Status
  • Metformin HCl
    1115-70-4
    Commercial
  • Sitagliptin Phosphate
    654671-77-9
    Commercial
  • Dapagliflozin
    461432-26-8
    Development
  • Empagliflozin
    864070-44-0
    Development
  • Vildagliptin
    274901-16-5
    Commercial
Request anti-diabetic quote
14+ products

Anti-Infective

Macrolides, fluoroquinolones, cephalosporins, and tetracyclines.

Category brochure
Product
CAS Number
Status
  • Azithromycin
    83905-01-5
    Commercial
  • Levofloxacin
    100986-85-4
    Commercial
  • Cefixime Trihydrate
    125110-14-7
    Commercial
  • Doxycycline Hyclate
    24390-14-5
    Commercial
  • Linezolid
    165800-03-3
    Commercial
Request anti-infective quote
8+ products

Oncology

Tyrosine kinase inhibitors and antimetabolites in contained suites.

Category brochure
Product
CAS Number
Status
  • Imatinib Mesylate
    220127-57-1
    Commercial
  • Erlotinib HCl
    183319-69-9
    Development
  • Gefitinib
    184475-35-2
    Commercial
  • Sorafenib Tosylate
    475207-59-1
    Development
  • Capecitabine
    154361-50-9
    Commercial
Request oncology quote
7+ products

CNS

SSRIs, anticonvulsants, and cognitive enhancers.

Category brochure
Product
CAS Number
Status
  • Escitalopram Oxalate
    219861-08-2
    Commercial
  • Sertraline HCl
    79559-97-0
    Commercial
  • Pregabalin
    148553-50-8
    Commercial
  • Donepezil HCl
    120011-70-3
    Commercial
  • Memantine HCl
    41100-52-1
    Commercial
Request cns quote
30+ products

Advanced Intermediates

Chiral building blocks, heterocyclic compounds, and custom multi-step synthesis.

Category brochure
Product
CAS Number
Status
  • Chiral building blocks
    —
  • Heterocyclic intermediates
    —
  • Boronic acids & esters
    —
  • Protected amino acid derivatives
    —
  • Custom multi-step synthesis
    —
Request advanced intermediates quote

Featured

Spotlight products

Molecules with active customer demand, validated processes, and ready-to-ship capacity.

Cardiovascular

Atorvastatin Calcium

CAS 134523-03-8

DMF available · multi-ton capacity

COA & DMF available
Anti-Diabetic

Sitagliptin Phosphate

CAS 654671-77-9

Validated 6-step route

COA & DMF available
Oncology

Imatinib Mesylate

CAS 220127-57-1

Contained suite · OEB-3

COA & DMF available

Downloads

Brochures & documentation

Download category-specific brochures. For COAs, DMFs, and stability data, please request via the quote form — we'll share under NDA.

Full Product Catalogue 2025
PDF · Complete portfolio across all therapy areas
Cardiovascular brochure
PDF · 12+ products in this category
Anti-Diabetic brochure
PDF · 9+ products in this category
Anti-Infective brochure
PDF · 14+ products in this category
Oncology brochure
PDF · 8+ products in this category
CNS brochure
PDF · 7+ products in this category
Advanced Intermediates brochure
PDF · 30+ products in this category

Need a product not listed here?

We routinely develop custom syntheses for partners. Share your structure and target specification and we'll respond with a feasibility note within 48 hours.

Request Custom Synthesis